Literature DB >> 621273

Control of the acute phase response. Serum C-reactive protein kinetics after acute myocardial infarction.

I Kushner, M L Broder, D Karp.   

Abstract

In order to investigate the magnitude and kinetics of the C-reactive protein (CRP) response after differing degrees of tissue injury, we studied changes in serum concentration of this acute phase protein in 19 patients after mild or extensive acute myocardial infarction. An increase in serum CRP concentration was seen in all patients. The rate of increase in concentration was found to be exponential, with a mean hourly rate constant for the entire group of patients of 0.085 (doubling time, 8.2 h). Patients with extensive infarction attained mean serum CRP levels about 4 times as great as did patients with mild infarction. No difference could be shown in the mean rate constant between these groups, the greater CRP response in the former group resulting principally from a more protracted period of rise in serum CRP concentration. A lag period before serum CRP levels began to rise was noted in only 4 of the 13 patients in whom this could be assessed. 7 of 10 patients with presumed unstable angina (coronary insufficiency) showed no rise in CRP concentration, while a small increase as noted in 3 patients. The data suggest that acute tissue injury, such as myocardial infarction, rapidly leads to acceleration in synthesis of CRP, and that the duration of this period of acceleration is related to the extent of tissue injury.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 621273      PMCID: PMC372532          DOI: 10.1172/JCI108932

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  21 in total

1.  Diagnostic aids in acute myocardial infarction: clinical and experimental.

Authors:  S LOSNER; B W VOLK; S M ARONSON
Journal:  Am Heart J       Date:  1957-08       Impact factor: 4.749

2.  Serologic tests for inflammation; serum complement, c-reactive protein and erythrocyte sedimentation rate in myocardial infarction.

Authors:  A J BOLTAX; E E FISCHEL
Journal:  Am J Med       Date:  1956-03       Impact factor: 4.965

3.  Rabbit CRP response to endotoxin administration: dose-response relationship and kinetics.

Authors:  B Yen-Watson; I Kushner
Journal:  Proc Soc Exp Biol Med       Date:  1974-09

4.  Comparative testing of precipitation methods for quantitation of C-reactive protein in blood serum.

Authors:  L A Nilsson
Journal:  Acta Pathol Microbiol Scand       Date:  1968

Review 5.  The kinetics of antibody formation.

Authors:  J W Uhr; M S Finkelstein
Journal:  Prog Allergy       Date:  1967

6.  Automated assay of lactate dehydrogenase in urine.

Authors:  N J Hochella; S Weinhouse
Journal:  Anal Biochem       Date:  1965-11       Impact factor: 3.365

7.  Radioimmunoassay of human C-reactive protein and levels in normal sera.

Authors:  D R Claus; A P Osmand; H Gewurz
Journal:  J Lab Clin Med       Date:  1976-01

8.  Molecular size of rabbit C-reactive protein synthesized in vitro.

Authors:  I Kushner; J Somerville-Volanakis
Journal:  J Lab Clin Med       Date:  1976-04

9.  Interactions of C-reactive protein with the complement system. I. Protamine-induced consumption of complement in acute phase sera.

Authors:  J Siegel; R Rent; H Gewurz
Journal:  J Exp Med       Date:  1974-09-01       Impact factor: 14.307

10.  Interactions of C-reactive protein with the complement system. II. C-reactive protein-mediated consumption of complement by poly-L-lysine polymers and other polycations.

Authors:  J Siegel; A P Osmand; M F Wilson; H Gewurz
Journal:  J Exp Med       Date:  1975-09-01       Impact factor: 14.307

View more
  52 in total

1.  Acute phase response after myocardial infarction: correlation between serum levels of cytokines and C-reactive protein.

Authors:  H Tilg; J Mair; M Herold; W E Aulitzky; P Lechleitner; F Dienstl; C Huber
Journal:  Klin Wochenschr       Date:  1990-11-09

2.  Serum cytokine profiles in experimental human malaria. Relationship to protection and disease course after challenge.

Authors:  R Harpaz; R Edelman; S S Wasserman; M M Levine; J R Davis; M B Sztein
Journal:  J Clin Invest       Date:  1992-08       Impact factor: 14.808

3.  Left ventricular function and C-reactive protein levels in acute myocardial infarction.

Authors:  Adelaide M Arruda-Olson; Maurice Enriquez-Sarano; Francesca Bursi; Susan A Weston; Allan S Jaffe; Jill M Killian; Véronique L Roger
Journal:  Am J Cardiol       Date:  2010-04-01       Impact factor: 2.778

4.  A comparison of the acute-phase response in middle aged and elderly patients.

Authors:  J Woo; M Arumanayagam; D MacDonald; K S Woo
Journal:  Postgrad Med J       Date:  1989-01       Impact factor: 2.401

5.  Reliability and feasibility of a near patient test for C-reactive protein in primary care.

Authors:  F D Hobbs; J E Kenkre; Y H Carter; G H Thorpe; R L Holder
Journal:  Br J Gen Pract       Date:  1996-07       Impact factor: 5.386

6.  C reactive protein concentrations during long distance running.

Authors:  A F Strachan; T D Noakes; G Kotzenberg; A E Nel; F C de Beer
Journal:  Br Med J (Clin Res Ed)       Date:  1984-11-10

7.  Serum amyloid A (SAA) is an early biomarker of influenza virus disease in BALB/c, C57BL/2, Swiss-Webster, and DBA.2 mice.

Authors:  Almut H Vollmer; Makda S Gebre; Dale L Barnard
Journal:  Antiviral Res       Date:  2016-08-11       Impact factor: 5.970

8.  [Stress-metabolism after myocardial infarction-demonstrated by means of the behaviour of plasma proteins with short half-life (author's transl)].

Authors:  G Ollenschläger; H Gofferje; L Horbach; H Prestele; K Schultis
Journal:  Klin Wochenschr       Date:  1981-05-04

9.  In vivo studies of serum C-reactive protein turnover in rabbits.

Authors:  M Chelladurai; S S Macintyre; I Kushner
Journal:  J Clin Invest       Date:  1983-03       Impact factor: 14.808

10.  C-reactive protein and bacterial infection in preterm infants.

Authors:  A Wasunna; A Whitelaw; R Gallimore; P N Hawkins; M B Pepys
Journal:  Eur J Pediatr       Date:  1990-03       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.